WatchGov

Indiana bills · 2026 Regular Session

Indiana SB 262

INSPECT program.

  1. Introduced
  2. In committee
  3. Passed Senate
  4. Passed House
  5. To Governor
  6. Became law

Sponsors

Cosponsors (2)

Summary

Official abstract published by the Indiana legislature· Digest

Sets forth the circumstances in which a dispenser is not required to transmit certain information to the INSPECT program (program). Requires an opioid treatment program to, before reporting patient information to the program, comply with federal regulations in obtaining patient consent. Allows the board of pharmacy to disclose prescription drug monitoring program data to a representative of the Indiana department of health and the office of the secretary of family and social services for specified purposes.

Text versions

Roll-call votes

State vote data last updated Oct 14, 2026, 8:13 PM.

DateVoteResultYour legislators
Feb 25, 2026
Senate
SB 262 - CriderpassSet your home in Indiana to see
Feb 23, 2026
House
SB 262 - Goss-Reaves - 3rd ReadingpassSet your home in Indiana to see
Jan 28, 2026
Senate
SB 262 - Crider - 3rd ReadingpassSet your home in Indiana to see

Actions